Evren Alici, MD, PhD

PI, cell and gene therapy group
Dept. of Medicine, Division of hematology
Karolinska Institutet
Interested in Multiple Myeloma and natural killer cells

[Evren Alici, MD, PhD @ealici]

@ScientistTess 100%

[Rizwan Romee @romeerizwan]

Genome-wide CRISPR screens in primary NK cells have been a major challenge! Very proud of @MichalSheffer for making it happen, keen to share the full story soon! @DanaFarber

[Rizwan Romee @romeerizwan]

Incredibly proud of ⁦⁦@graceandscience⁩ from my lab who is presenting our work using mem-NK cells in MRD+ myeloma, collaboration with ⁦@TheBianchiLab⁩ ⁦@DanaFarber⁩ ⁦@DanaFarberNews⁩ #romeelab #NK #myeloma #ASH23

[Rizwan Romee @romeerizwan]

It was exciting to talk about NK cell/CAR translation ⁦@AACR⁩ (AACR/NCI/EORTC) annual meeting with Prof Miller and ⁦@ealici⁩ this morning #NK cells #Immunotherapy #romeelab

[Evren Alici, MD, PhD @ealici]

@MalmbergLab @SNI_NKMeeting @mjwsim @adesoton @DrFran_Colucci @thoren_lab @KathyHsuLab @NextGenNK_CC @InnatePharma Who won?

[Rafael Fonseca MD 🦔🇺🇸🏜🇲🇽 @Rfonsi1]

#EHA23RF #MMSM

[Nicole Marquardt @NicoleMarquard9]

We are #hiring! Looking for an enthusiastic Postdoctoral Fellow with a particular interest in NK cells in human tissues.

More info about the position and how to apply:

https://t.co/IagNHrgh6Z https://t.co/da53WRS0jj

[Evren Alici, MD, PhD @ealici]

@MalmbergLab @SNI_NKMeeting Now this is exciting!

[Evren Alici, MD, PhD @ealici]

@Dr_Nick_Bikes @HansonWade It was wonderful to see you!

[SNI NK Meeting @SNI_NKMeeting]

The #NK2023 conference is now full, but we have a waiting list activated. We are working on possibilities to increase the participant number, so please sign up on the list and you will be informed if we have extra space.

[MalmbergLab @MalmbergLab]

Absolutely fantastic to see the meeting filled up six month ahead of time. There might be some slots available on the clincal day and please sign up on the waiting list in case we can expand…

[Radiumhemmets Forskningsfonder @cancerforskning]

Andreas Lundqvist tillträtt nyinrättad professur i onkologisk immunterapi – initierad och delfinansierad av Radiumhemmets Forskningsfonder.

https://t.co/I2t7vthxfs

[Evren Alici, MD, PhD @ealici]

@HadidiSamer An arm with boosting the cd16a engaging steady state effector population may yield pronounced better responses.

[Samer Al Hadidi, MD,MS,FACP @HadidiSamer]

RO7297089: a bispecific tetravalent antibody targeting BCMA and CD16a, (expressed on innate immune cells including NK cells/macrophages)

Presented 1st at #ASH21

🛑 Efficacy results discouraging 👇
PR in 7%
SD 52%

#mmsm

https://t.co/2EAI858RSo

[Vycellix @vycellix]

#NK2023 The world’s foremost cell therapy key opinion leader innovators advancing next-generation natural killer (NK)-based therapies will present latest breakthrough discoveries at NK2023, Oslo, Norway, in September!

[Evren Alici, MD, PhD @ealici]

@SNI_NKMeeting Fantastic! We are all looking forward.

[Evren Alici, MD, PhD @ealici]

@romeerizwan Hope you get a chance to see the city!

[Evren Alici, MD, PhD @ealici]

@MalmbergLab @lab_rezvani @romeerizwan @EricVivier1 It was a really nice compilation.

[MalmbergLab @MalmbergLab]

#ASH2022 Distinguished panel covering prospects for harnessing NK cells in precision immunotherapy

[Evren Alici, MD, PhD @ealici]

Thank you for your generous continued support!

[Radiumhemmets Forskningsfonder @cancerforskning]

I år delar vi ut 80 miljoner till patientnära cancerforskning! ✨ Stödet går till bl.a. projekt med fokus på specifika diagnoser, ökad kunskap om tumörers egenskaper samt prevention, förbättrad diagnostik & behandling. Tack alla er som bidrar med gåvor!
https://t.co/gwi2KS8kBu